Lucas Jacob W, Ghiraldi Eric, Ellis Jeffrey, Friedlander Justin I
Department of Urology, Einstein Healthcare Network, 1200 Tabor Road, 3rd Floor Sley Building, Philadelphia, PA, 19141, USA.
Division of Urology and Urologic Oncology, Temple Health and the Fox Chase Cancer Center, Philadelphia, PA, USA.
Curr Urol Rep. 2018 Mar 2;19(4):24. doi: 10.1007/s11934-018-0773-4.
This review focuses on the role of endoscopic treatment of ureteral stricture disease (USD) in the era of minimally invasive surgery.
There is a relative paucity of recent literature regarding the endoscopic treatment of USD. Laser endopyelotomy and balloon dilation are associated with good outcomes in treatment-naïve patients with short (< 2 cm), non-ischemic, benign ureteral strictures with a functional renal unit. If stricture recurs, repetitive dilation and laser endopyleotomy is not recommended, as success rates are low in this scenario. Patients with low-complexity ureteroenteric strictures and transplant strictures may benefit from endoscopic treatment options, although formal reconstruction offers higher rates of success. Formal ureteral reconstruction remains the gold-standard treatment for ureteral stricture disease as it is associated with higher rates of complete resolution. However, in carefully selected patients, endoscopic treatment modalities provide a low-cost, low-morbidity alternative.
本综述聚焦于输尿管狭窄疾病(USD)的内镜治疗在微创手术时代的作用。
近期关于USD内镜治疗的文献相对较少。激光肾盂内切开术和球囊扩张术对于初治的、狭窄段短(<2厘米)、非缺血性、伴有功能肾单位的良性输尿管狭窄患者疗效良好。如果狭窄复发,不建议重复扩张和激光肾盂内切开术,因为这种情况下成功率较低。低复杂性输尿管肠吻合口狭窄和移植肾狭窄患者可能从内镜治疗中获益,尽管正规重建手术成功率更高。正规输尿管重建仍然是输尿管狭窄疾病的金标准治疗方法,因为其完全缓解率更高。然而,在经过精心挑选的患者中,内镜治疗方式提供了一种低成本、低发病率的替代方案。